Title Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer
Authors Xian, Hai-Peng
Zhuo, Zhong-Ling
Sun, Yu-Jing
Liang, Bin
Zhao, Xiao-Tao
Affiliation Peking Univ, Peoples Hosp, Dept Clin Lab, 11 Xi Zhimen South St, Beijing 100044, Peoples R China.
Peking Univ, Dept Clin Lab, Int Hosp, Beijing 100044, Peoples R China.
Peking Univ, Peoples Hosp, Dept Surg Gastroenterol, 11 Xi Zhimen South St, Beijing 100044, Peoples R China.
Peking Univ, Peoples Hosp, Dept Clin Lab, 11 Xi Zhimen South St, Beijing 100044, Peoples R China.
Liang, B (reprint author), Peking Univ, Peoples Hosp, Dept Surg Gastroenterol, 11 Xi Zhimen South St, Beijing 100044, Peoples R China.
Keywords gastric cancer
long non-coding RNA
HULC
ZNFX1-AS1
tumor marker
CELL-PROLIFERATION
POOR-PROGNOSIS
EXPRESSION
PROGRESSION
ZFAS1
Issue Date 2018
Publisher ONCOLOGY LETTERS
Citation ONCOLOGY LETTERS. 2018, 16(4), 4689-4698.
Abstract Long non-coding RNAs (lncRNAs) have been demonstrated to be involved in different types of cancer, including gastric cancer. Although altered lncRNAs profiles have been observed in or around gastric cancer tissues, the diagnostic value of circulating lncRNAs in gastric cancer remains unclear. In the present study, a number of highly expressed lncRNAs, including uc001lsz, GACAT2, ABHD11-AS1, GACAT3, SUMP1P3, CHET1, TUG1, SNHG12, GAS5, PVT1, LINC00152, HOTAIR, CCAT1, H19, HULC and ZNFX1-AS1, were investigated as potential minimally invasive biomarkers for this tumor. Preliminary screening experiments revealed that ZNFX1-AS1 and HULC were differentially expressed in the plasma of gastric cancer patients and healthy control subjects. The study further examined the relative expression of ZNFX1-AS1 and HULC in the plasma of 50 matching preoperative and postoperative patients, 50 gastrointestinal stromal tumor (GIST) patients, 50 gastritis/peptic ulcer patients and 50 healthy control subjects through reverse transcription-quantitative polymerase chain reaction. The correlation of lncRNA relative expression with the general characteristics and clinicopathological factors was analyzed. It was observed that the levels of ZNFX1-AS1 and HULC in the plasma of preoperative patients were markedly higher compared with those in the plasma of GIST patients, gastritis/peptic ulcer patients and healthy control subjects, while no significant difference was detected among these three groups. Receiver operating characteristic curve analysis was also conducted to distinguish gastric cancer patients from healthy control subjects. The area under the curve was 0.85 and 0.65 for ZNFX1-AS1 and HULC, respectively. In conclusion, the results indicated that the lncRNAs ZNFX1-AS1 and HULC are promising in the clinical diagnosis of gastric cancer.
URI http://hdl.handle.net/20.500.11897/517048
ISSN 1792-1074
DOI 10.3892/ol.2018.9199
Indexed SCI(E)
PubMed
Medline
Appears in Collections: 人民医院
国际医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.